REFLECTION PHARMA LTD

Company number 08917697 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£600k -£400k -£200k £0 £200k £400k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £21,575 Total assets 2017: £15,224 Total assets 2018: £136,085 Total assets 2019: £129,792 Total assets 2020: £356,198 Total assets 2021: £190,106 Total assets 2022: £153,452 Total assets 2023: £137,236 Total assets 2024: £145,646 Total assets 2025: £131,824 Total assets Net assets 2017: £3,880 Net assets 2018: £12,085 Net assets 2019: -£113,043 Net assets 2020: £7,445 Net assets 2021: -£226,856 Net assets 2022: -£224,364 Net assets 2023: -£299,550 Net assets 2024: -£376,855 Net assets 2025: -£431,596 Net assets Total liabilities 2016: -£17,192 Total liabilities 2017: -£11,344 Total liabilities 2018: -£100,000 Total liabilities 2019: -£135,118 Total liabilities 2020: -£258,683 Total liabilities 2021: -£327,741 Total liabilities 2022: -£209,126 Total liabilities 2023: -£307,161 Total liabilities 2024: -£396,027 Total liabilities 2025: -£504,102 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 1 2 3 4 5 2024 2025 2024: 5 2025: 4

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 12 years

Latest accounts (2025-03-29): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-03-29 £131,824 -£504,102 -£431,596 4
2024-03-29 £145,646 -£396,027 -£376,855 5
2023-03-31 £137,236 -£307,161 -£299,550
2022-03-31 £153,452 -£209,126 -£224,364
2021-03-31 £190,106 -£327,741 -£226,856
2020-03-31 £356,198 -£258,683 £7,445
2019-03-31 £129,792 -£135,118 -£113,043
2018-03-31 £136,085 -£100,000 £12,085
2017-03-31 £15,224 -£11,344 £3,880
2016-03-31 £21,575 -£17,192
2015-03-31 £19,501 -£16,593 £11,605
2014-03-31 £10 £0 £10

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.